HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection.

Abstract
To investigate the role of type I interferon (IFN) and its regulatory transacting proteins, interferon regulatory factors (IRF-1 and IRF-2), in early protection against infection with virulent Venezuelan equine encephalitis virus (VEE), we utilized mice with targeted mutations in the IFN-alpha/beta receptor, IRF-1, or IRF-2 genes. IFN-alpha/beta-receptor knockout mice are highly susceptible to peripheral infection with virulent or attenuated VEE, resulting in their death within 24 and 48 h, respectively. Treatment of normal macrophages with anti-IFN-alpha/beta antibody prior to and during infection with molecularly cloned virulent VEE resulted in increased VEE replication. However, treatment with high doses of IFN or IFN-inducing agents failed to alter percentage mortality or average survival times in mice challenged with a low dose of virulent VEE. In IRF-1 and IRF-2 knockout mice (IRF-1(-/-) and IRF-2(-/-)), the 100% protection against virulent VEE that is conferred by attenuated VEE within 24 h in control C57BL/6 mice was completely absent in IRF-2(-/-) mice, whereas 50% of IRF-1(-/-) mice were protected. IRF-2(-/-) mice were deficient in clearing VEE virus from the spleen and the brain compared to the heterozygous IRF-2(+/-) knockout or C57BL/6 (+/+) mice. Furthermore, a distinct pattern of histopathological changes was observed in brains of IRF-2(-/-) mice after VEE exposure. Taken together, these findings imply that the altered immune response in IRF-1 and IRF-2 knockout mice results in altered virus dissemination, altered virus clearance, and altered virus-induced pathology. Thus, type I interferon, as well as IRF-1 and IRF-2, appears to play an important and necessary role in the pathogenesis of, and protection against, VEE infection.
AuthorsF B Grieder, S N Vogel
JournalVirology (Virology) Vol. 257 Issue 1 Pg. 106-18 (Apr 25 1999) ISSN: 0042-6822 [Print] United States
PMID10208925 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • DNA-Binding Proteins
  • Interferon Regulatory Factor-1
  • Interferon Regulatory Factor-2
  • Interferon Type I
  • Irf1 protein, mouse
  • Irf2 protein, mouse
  • Phosphoproteins
  • Repressor Proteins
  • Transcription Factors
  • Interferon-gamma
  • Interferons
Topics
  • Animals
  • DNA-Binding Proteins (genetics, physiology)
  • Encephalitis Virus, Venezuelan Equine (pathogenicity)
  • Encephalomyelitis, Venezuelan Equine (prevention & control)
  • Gene Targeting
  • Interferon Regulatory Factor-1
  • Interferon Regulatory Factor-2
  • Interferon Type I (genetics, physiology)
  • Interferon-gamma (genetics, physiology)
  • Interferons (genetics, physiology)
  • Macrophages, Peritoneal (virology)
  • Mice
  • Phosphoproteins (genetics, physiology)
  • Repressor Proteins (genetics, physiology)
  • Transcription Factors (genetics, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: